Abstract
Objective: Previous results have associated elevated bromodomain and extraterminal 4 (BRD4) expression with poor overall survival in ovarian cancer. However, patterns of BRD4 expression in advanced-stage high-grade serous ovarian cancer (HGSOC) are not well characterized. The aim of this study was to evaluate BRD4 protein expression in primary and metastatic tumors of advanced-stage HGSOC.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
